Softbank-backed Flagship startup lays off 65, replaces CEO


Repertoire Immune Medicines, the startup formed in 2020 from the merging of two Flagship Pioneering companies, has scrapped its two lead drugs, replaced its CEO and laid off 65 people — nearly half its staff.

Previous Syneos Health sees 'unacceptable' earnings results as headwinds continue
Next Popular Il Fornaio restaurant expanding to Mountain View